James J. Harding MD – MSK Gastrointestinal Oncologist & Early Drug Development Specialist is a medical oncologist based in New York, New York, specializing in gastrointestinal cancers. Located in the 10022 postal code area, this practice focuses on the diagnosis and treatment of liver cancer, gallbladder cancer, bile duct cancer, and other malignancies within the gastrointestinal tract. The office is accessible by appointment and can be reached at 347-929-3164 for consultations and patient inquiries.
As an oncologist, Dr. Harding combines expertise in clinical care with a focus on early drug development, contributing to advancing treatment options for patients with complex gastrointestinal cancers. The approach emphasizes personalized treatment plans tailored to the specific type and stage of cancer, integrating the latest research and clinical trial opportunities. This specialization ensures patients receive cutting-edge therapies alongside conventional treatments, reflecting the evolving landscape of oncology care.
Located within a major medical center in New York City, this practice benefits from access to multidisciplinary teams and state-of-the-art medical resources. Patients receive comprehensive evaluations that include diagnostic imaging, biopsy, and laboratory studies to guide precise treatment strategies. Collaboration with surgeons, radiologists, and other specialists supports coordinated care, aiming to improve outcomes and quality of life for those facing gastrointestinal cancers.
James J. Harding MD’s practice is dedicated to addressing the complexities of gastrointestinal oncology in a metropolitan setting. The combination of clinical expertise and involvement in early drug development offers patients options beyond standard care, contributing to the broader effort of improving cancer treatment protocols. This focus on both patient care and research reflects the dual priorities of managing current cases and exploring new therapies for future patients.
